Human UFSP1 Translated from an Upstream Near-cognate Initiation Codon Functions As an Active UFM1-specific Protease
Overview
Affiliations
Ubiquitin-fold modifier 1 (UFM1) is a recently identified ubiquitin-like posttranslational modification with important biological functions. However, the regulatory mechanisms governing UFM1 modification of target proteins (UFMylation) and the cellular processes controlled by UFMylation remain largely unknown. It has been previously shown that a UFM1-specific protease (UFSP2) mediates the maturation of the UFM1 precursor and drives the de-UFMylation reaction. Furthermore, it has long been thought that UFSP1, an ortholog of UFSP2, is inactive in many organisms, including human, because it lacks an apparent protease domain when translated from the canonical start codon (AUG). Here, we demonstrate using the combination of site-directed mutagenesis, CRISPR/Cas9-mediated genome editing, and mass spectrometry approaches that translation of human UFSP1 initiates from an upstream near-cognate codon, CUG, via eukaryotic translation initiation factor eIF2A-mediated translational initiation rather than from the annotated AUG, revealing the presence of a catalytic protease domain containing a Cys active site. Moreover, we show that both UFSP1 and UFSP2 mediate maturation of UFM1 and de-UFMylation of target proteins. This study demonstrates that human UFSP1 functions as an active UFM1-specific protease, thus contributing to our understanding of the UFMylation/de-UFMylation process.
Protocol for the purification and analysis of nuclear UFMylated proteins.
Panichnantakul P, Oeffinger M STAR Protoc. 2025; 6(1):103634.
PMID: 39937649 PMC: 11869847. DOI: 10.1016/j.xpro.2025.103634.
UFMylation promotes orthoflavivirus infectious particle production.
Schmidt H, Sorensen G, Lanahan M, Grabowski J, Park M, Horner S bioRxiv. 2025; .
PMID: 39829754 PMC: 11741389. DOI: 10.1101/2025.01.09.632082.
Multifaceted roles of UFMylation in health and disease.
Wang R, Li L, Zhou J, Ran J Acta Pharmacol Sin. 2025; .
PMID: 39775503 DOI: 10.1038/s41401-024-01456-9.
The UFMylation pathway is impaired in Alzheimer's disease.
Yan T, Heckman M, Craver E, Liu C, Rawlinson B, Wang X Mol Neurodegener. 2024; 19(1):97.
PMID: 39696466 PMC: 11656649. DOI: 10.1186/s13024-024-00784-y.
The emerging roles of UFMylation in the modulation of immune responses.
Liang Z, Ning R, Wang Z, Kong X, Yan Y, Cai Y Clin Transl Med. 2024; 14(9):e70019.
PMID: 39259506 PMC: 11389534. DOI: 10.1002/ctm2.70019.